Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Glass

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Vitamins and Hormones|August 4, 2009
Anandamide receptor signal transductionCatherine E Goodfellow, Michelle Glass
Current Opinion in Pharmacology|November 16, 2024
Could positive allosteric modulators of the cannabinoid CB<sub>1</sub> receptor be efficacious and safe for the treatment of chronic pain?Hayley M Green, Michelle Glass
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoidsSean D McAllister, Michelle Glass
Gene|August 12, 2003
Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebratesJohn M McPartland, Michelle Glass
The New Zealand Medical Journal|May 4, 2019
What is medicinal cannabis?Michelle Glass, John C Ashton
Current Neuropharmacology|July 11, 2008
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegenerationJohn C Ashton, Michelle Glass
Journal of Pharmacological and Toxicological Methods|December 6, 2014
Increasing the flexibility of the LANCE cAMP detection kitMorag Rose Hunter, Michelle Glass
Advances in Pharmacology (San Diego, Calif.)|August 23, 2017
Functional Selectivity at Cannabinoid ReceptorsRichard Priestley, Michelle Glass, David Kendall
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 20, 2003
Cannabis, cannabinoids and reproductionBoram Park, John M McPartland, Michelle Glass
Cellular Signalling|December 1, 2020
Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonistsMonica Patel, David B Finlay, Michelle Glass
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Vitamins and Hormones|August 4, 2009
Anandamide receptor signal transductionCatherine E Goodfellow, Michelle Glass
Current Opinion in Pharmacology|November 16, 2024
Could positive allosteric modulators of the cannabinoid CB<sub>1</sub> receptor be efficacious and safe for the treatment of chronic pain?Hayley M Green, Michelle Glass
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoidsSean D McAllister, Michelle Glass
Gene|August 12, 2003
Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebratesJohn M McPartland, Michelle Glass
The New Zealand Medical Journal|May 4, 2019
What is medicinal cannabis?Michelle Glass, John C Ashton
Current Neuropharmacology|July 11, 2008
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegenerationJohn C Ashton, Michelle Glass
Journal of Pharmacological and Toxicological Methods|December 6, 2014
Increasing the flexibility of the LANCE cAMP detection kitMorag Rose Hunter, Michelle Glass
Advances in Pharmacology (San Diego, Calif.)|August 23, 2017
Functional Selectivity at Cannabinoid ReceptorsRichard Priestley, Michelle Glass, David Kendall
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 20, 2003
Cannabis, cannabinoids and reproductionBoram Park, John M McPartland, Michelle Glass
Cellular Signalling|December 1, 2020
Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonistsMonica Patel, David B Finlay, Michelle Glass
Pageof 13